Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GC Cell Obtains Anti-bribery Management System Certification 2023-04-06 18:03
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio 2023-04-06 10:20
Chula Makes Progress in "CAR T-Cell Therapy" Innovation: New Hope for Thai Lymphoma Cancer Patients 2023-04-06 10:00
Luye Pharma and Duopharma Reach Strategic Partnership to Expand Accessibility of Cholesterol Management Products in Malaysia 2023-04-05 10:44
AMPLIFY HEALTH ASIA PTE LIMITED APPOINTS DAVID FRANKENFIELD AS CHIEF DATA OFFICER 2023-04-05 09:00
Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology 2023-04-05 07:00
Goodwin Biotechnology Inc. (GBI) Announces First Commercial Contract Signing 2023-04-04 20:57
Biosion Initiates Phase II Clinical Trial of BSI-045B in Atopic Dermatitis 2023-04-04 20:50
Metabolon Launches Bile Acids and Short Chain Fatty Acids Targeted Panels to Advance Understanding of Microbiome and Gut Metabolome in Health and Disease 2023-04-04 20:03
Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects 2023-04-04 20:00
Latest Updates of 6 Viva's Portfolio Companies 2023-04-04 19:39
iNtRON confirms cancer-controlling effect of PHAGERIA® drug candidate in the organoid model. 2023-04-04 10:33
Bridgewest Group completes acquisition of sterile injectable manufacturing plant in Western Australia from Pfizer 2023-04-04 10:00
Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects 2023-04-04 08:00
AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc. 2023-04-03 21:00
GC Cell and New Management Embarking on a New Chapter 2023-04-03 16:47
Harbour BioMed Reports Full Year 2022 Financial Results 2023-04-03 15:10
The World's Second Approved Biosimilars of Denosumab (MAILISHU) 2023-04-03 13:44
CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner 2023-04-01 10:00
Henlius 2022 Annual Results: Significant Achievements in Commercialisation, Surged to RMB3.2 Billion in Revenues 2023-04-01 00:06
1 115 116 117 118 119 452